Rogosin Institute — New York, New York

Rogosin Institute is a clinical research site located in New York, New York, United States 10021.

Crixeo Health Trust Score: 68/100 (FAIR). This profile has not yet been claimed by the site owner.

Rogosin Institute has participated in 4 clinical trials.

Therapeutic areas: Autosomal Dominant Polycystic Kidney, ADPKD, End Stage Renal Disease.

Sponsors: Kadmon, a Sanofi Company, Outset Medical, Otsuka Pharmaceutical Development & Commercialization, Inc..

Sponsor Feasibility Report

Trust Score: 68/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Rogosin Institute?

Rogosin Institute has a Crixeo Trust Score of 68/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Rogosin Institute conducted?

Rogosin Institute has 4 clinical trials on record. Their work covers Autosomal Dominant Polycystic Kidney, ADPKD, End Stage Renal Disease.

Is Rogosin Institute accredited by Crixeo Health?

Rogosin Institute has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Rogosin Institute?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.